Abstract: A dual braided catheter shaft includes an inner helical braid and outer helical braid than encapsulate an axially extending steering wire there between. In one embodiment, the shaft includes an inner polymer jacket, an inner braid formed on the inner jacket, a steering wire disposed along an outside surface of the inner braid, an outer braid formed over the inner braid and steering wire assembly and an outer jacket formed on the outer braid. The braiding parameters of the inner and outer braids can be varied along the length of the catheter to provide varying mechanical properties.

Abstract: The present invention describes a securement device that maintains proper placement of a percutaneous catheter and incorporates a universal fitting for the attachment of various, interchangeable, active and passive technologies. The securement device includes a unique catheter hub that enables attachment of active technology to provide diagnostic, therapeutic, and monitoring applications of physiologic, anatomic, and other clinically relevant properties or conditions. The securement device also includes a primary semi-flexible polymeric retention member (the “base”) positioned atop, or integrated with, a thin flexible adhesive pad. The adhesive pad has a first surface with an adhesive substrate and a second surface configured to receive the base. The hub is received within the base and a cap is used to secure the hub to the base.

Abstract: An anchoring system for securing a catheter to a patient includes an anchor pad and a retainer. The retainer is supported by the anchor pad and may include a base and a cover. A groove upon the base can be arranged to receive a branching site of a catheter where the lumens merge distal to the insertion site. One or more posts may also protrude from the base to the cover at a position disposed between the two distal branches of the catheter. The cover closes over the base securing the branching site between the groove and the posts. The contact between the retainer and catheter thereby inhibits inadvertent motion of the catheter upon the patient. A latch mechanism may be disposed upon the retainer to maintain the cover in a closed position over the branching site of the catheter on the base.

Abstract: A catheter assembly includes a hollow catheter; a catheter hub to which the catheter is fixed; an inner needle including a needle tip, the inner needle being detachably disposed inside of the catheter; a needle hub to which the inner needle is fixed; a catheter operation member configured to move the catheter relative to the inner needle; and a support member disposed at the needle hub. The support member includes a support main body portion that is movable between (i) a first position located on a side of the catheter opposite the catheter operation member, at which the catheter is interposed between the support member and the catheter operation member, and the support main body portion contacts and supports the catheter, and (ii) a second position that is a different position from the first position, at which the support main body portion does not contact the catheter.

Abstract: A catheter insertion device, including a housing having a base (504, 604, 704), a flexible beam (510, 610, 710) movably disposed within the housing, an insertion needle (514, 614) connected with the beam, and a holder (518, 618, 718) movably disposed within the housing and movably connected with the insertion needle. The device also includes a catheter (522, 622, 722) connected with the holder to displace therewith, the catheter surrounding at least a portion of the insertion needle, and an actuator button (502, 602, 702) movably connected to the housing and configured to flex the beam upon actuation, thereby displacing the insertion needle and the catheter to an extended position in which respective distal portions of the insertion needle and the catheter extend outside the housing through the base.

Abstract: A catheter assembly includes a flexible catheter (22), a needle (12) having a sharp distal tip, the needle (12) disposed in the flexible catheter (22) and moving from a first position that exposes the needle (12) to a second position, an outer member (26) that is configured to engage and disengage a catheter hub (14), an inner member (28) disposed in the outer member (26), and a needle protection (30) member disposed in the inner member (28), the needle protection member (30) enclosing at least a portion of the needle (12) when the needle (12) is in the second position.

Abstract: A catheter unit for use in an intravenous catheter instrument is provided. The catheter unit comprises a catheter hub and a catheter extending distally from the catheter hub. The catheter has a lumen being in flow communication with an interior cavity of the catheter hub. The interior cavity is provided with a cooperation groove at a proximal zone of the interior cavity. A catheter instrument, comprising such a catheter unit, is also provided.

Abstract: A device for manipulating a wire includes a first structure and a second structure pivotably mounted with respect to each other so as to define respective facing surfaces configured for alternating between a closed position and at least one open position, where each of the respective facing surfaces includes one or more detent elements and one or more tooth elements extending therefrom. In the device, the tooth elements of the first structure and the second structure are in an interlocking and overlapping arrangement in at least the closed position. Further, each of the tooth elements has a concave surface for defining a passage between the facing surface in the at least one open position. Additionally, each of the detent elements is arranged to face the concave surface of one of the tooth elements of an opposite one of the respective facing surfaces in the closed position.

Abstract: A guidewire manipulation device includes a housing configured to be supported by the hand of a user, the housing having a distal end and a proximal end, the housing configured to allow a guidewire to be placed therethrough and extend between the distal end and proximal end, a drive system carried by the housing and configured to drive rotation of the guidewire, and a manual input module carried by the housing, the manual input module configured to allow one or more fingers of the hand of the user to manually stop or slow the rotation of the guidewire while the housing is supported by the hand of the user.

Abstract: An elongated, tubular-shaped balloon for a balloon catheter includes three regions along its length, in sequence: a proximal region, an intermediate region, and a distal region. The intermediate region is defined by a curved outer surface that is established by a radius of curvature r1. Similarly, a curved inner surface for the intermediate region is established by a radius of curvature r2, wherein r1?r2. Balloon thickness at the center of the intermediate region is tc, while balloon thickness in both the proximal and distal regions is t (t>tc). The stretchability and bendability of the balloon material is directly proportional to the thickness of the balloon, to thereby shape the balloon as a prolate spheroid when inflated.

Abstract: Fluid delivery or removal systems and methods for use during a medical procedure are disclosed. A system can include a base member, a receptacle configured to be received by a chamber of the base member, and a pressure sensor. The base member can include a piston having the pressure sensor positioned at or near its tip, a powered actuator for imparting motive forces to the piston, and a rechargeable power supply to energize the actuator. The receptacle is configured to contain a volume of fluid partially retained by a seal member. A surface of the seal member opposite the fluid can include a cavity to receive and engage the piston's tip when the receptacle is placed in the chamber. Based on a user-defined parameter input (e.g., a desired pressure set point) received by the system, the piston can be driven in an axial direction by the powered actuator, thereby urging an amount of fluid through a distal opening in the receptacle.

Abstract: An inflatable structure for use in biological lumens and methods of making and using the same are disclosed. The structure can have an inflatable balloon encircled by a shell. The shell can have proximal and distal tapered necks, longitudinally-oriented flutes, and apertures at the proximal and distal ends of the shell. The apertures can be recessed in the flutes in the necks. The shell can also have fiber reinforced walls.

Abstract: Disclosed is an arterial access sheath for introducing an interventional device into an artery. The arterial access sheath includes an elongated body sized and shaped to be transcervically introduced into a common carotid artery at an access location in the neck and an internal lumen in the elongated body having a proximal opening in a proximal region of the elongated body and a distal opening in a distal region of the elongated body. The internal lumen provides a passageway for introducing an interventional device into the common carotid artery when the elongated body is positioned in the common carotid artery. The elongated body has a proximal section and a distalmost section that is more flexible than the proximal section. A ratio of an entire length of the distalmost section to an overall length of the sheath body is one tenth to one half the overall length of the sheath body.

Abstract: The present invention is premised upon an improved balloon dilator, more particularly to an improved balloon dilator comprising an expandable balloon, a core wire which extends through the expandable balloon, and a single visual marker band positioned at a geometric center within the balloon dilator which may selectively reflect certain wavelengths of light.

Abstract: The invention pertains to implantable medical devices for controlled delivery of therapeutic agents. Some devices according to the invention have a titanium reservoir, and a porous titanium oxide based membrane to control the rate of release of the therapeutic agent. The reservoir contains a formulation of the active agent, and means to promote water uptake into the reservoir upon implantation. In some embodiments the means include a gas with a higher solubility in than air water.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: Devices, systems, and methods for localized drug delivery. In at least one embodiment of a method of localized drug delivery, the method comprises the steps of placing a resorbable device within a tube, introducing the tube within a mammalian body at or near a tissue and/or organ within the mammalian body, and anchoring the resorbable device to the tissue and/or organ. Devices and systems useful for performing such a method are also disclosed herein, wherein an exemplary device comprises at least one drug release portion having at least one drug to be released over time and a binder intermixed with the at least one drug, and at least one resorbable anchor portion coupled to the at least one drug release portion.

Abstract: A controller, which may be used in a transdermal drug delivery apparatus, includes a housing, a pushing mechanism mounted for moving relative to the housing, a force provider positioned between the housing and the pushing mechanism for moving the pushing mechanism relative to the housing, and a latching mechanism for selectively restricting and allowing relative movement between the housing and the pushing mechanism. The pushing mechanism may be configured for pushing against a reservoir of the transdermal drug delivery apparatus. The latching mechanism may include flexible arms extending between the opposite ends of the latching mechanism, and the latching mechanism may be configured so that the arms release the pushing mechanism in response to the opposite ends being forced toward one another.

Abstract: The present invention provides methods utilizing current nano-technological processes for fabricating a range of micro-devices with significantly expanded capabilities, unique functionalities at microscopic levels, enhanced degree of flexibilities, reduced costs and improved performance in the fields of bioscience and medicine. Such fabricated micro-devices have significant improvements in many areas over the existing, conventional methods, which include, but are not limited to reduced overall costs, early disease detection, targeted drug delivery, targeted disease treatment and reduced degree of invasiveness in treatment.

Abstract: A receptacle, which may be suitable for use as a portion of a transdermal drug delivery apparatus, may include a housing for being fastened to the user, a force provider that is elastic, at least one deformable component, and a microneedle assembly movably mounted to the housing for moving inwardly and outwardly relative to the housing. The force provider may be positioned between the housing and the microneedle assembly for forcing the microneedle assembly outwardly relative to the housing and against the skin of the user. The at least one deformable component may be connected between the microneedle assembly and the housing for both allowing relative movement between the microneedle assembly and the housing, and at least partially restricting the microneedle assembly from falling away from the housing.

Abstract: Methods to use medical imaging to monitor the molecule penetration into CNS during ultrasound-mediated delivery are disclosed. The method states a two-step process to predict the amount of molecular penetration which is based on the observation of medical imaging. The first is to propose a unified exposure input to unify the exposure condition so as to build a transferred relation to imaging index. The second is to propose a unified imaging index to unify the imaging readout so as to build a reliable transferred relation to molecular concentration. Linking these two, the molecular penetration induced by ultrasound irradiation can be estimated from medical imaging with ultrasound exposure conditions and molecular sizes.

Abstract: A skin care device is provided. The skin care device includes a hand piece and a tip which is mounted at a front end of the hand piece and is configured to peel impurities off the surface of a skin as the tip contacts the skin. In the center of a front end surface of the tip, there is provided an input hole through which face wash liquid is inputted toward a skin, and at an edge portion thereof, there is formed a suction hole for sucking and discharging the face wash liquid, and a groove-shaped flow passage for guiding the flow of the face wash liquid between the input hole and the suction hole is formed at a front end surface of the tip, and a vibrator is mounted at an inner side of the tip, thus concurrently supplying vibrations to the tip and the face wash liquid.

Abstract: A method for reducing small volume subcutaneous leaks of therapeutic fluids during procedures to refill an implantable medical device includes reducing pressure in a reservoir of the device. A refill needle can be percutaneously inserted into a fill port in communication with the reservoir and therapeutic fluid can be delivered through the needle into the reservoir. Reduced reservoir pressure upon withdrawal of the refill needle from the port can result in reduced subcutaneous leakage of the therapeutic fluid.

Abstract: A venous access port assembly (10) having a housing base (28) with a discharge stem (16), a septum (14) and a cap (36). An interior reservoir (22) is defined by a well (30) in the housing base and the bottom surface of the septum, and a passageway (20) extends from the reservoir through the discharge stem (16). The cap (36) is secured to the housing base (28) and securely retains the septum in the assembly (10), compressing an annular flange (44) of the septum against a septum seat (46) of the housing base. Horizontal ribs on the interior of the cap snap into complementary grooves on the side wall of the housing base to mechanically lock together the cap and housing base during curing of the solvent bonding agent. The cap (48) is mechanically secured to the housing base (28) as well as being bonded thereto. Crush ribs (72) on the interior surface (68) of the cap (36), precisely center the cap about the housing base during assembly and compensating for manufacturing tolerances.

Abstract: A clamp for selectively compressing a portion of tubing, such as an extension leg of a PICC or other catheter, is disclosed. The clamp is able to be opened or closed with a thumb and finger of a single hand of a user and is slidably attached to the tubing so as to enable its placement as desired along the tube. In one embodiment, the tubing clamp comprises a body including first and second body portions hingedly connected to one another in a clamshell configuration, a latch for releasably latching the first and second body portions together, and at least two tube compression members. The tube compression members cooperate to compress and occlude a portion of tubing passing through the tubing clamp when the first and second body portions are latched to one another.

Abstract: The present application relates to a device for the electroporation of bacterial cells in or on a surface of the Stratum corneum layer of a person's skin. It comprises electrodes positionable in the vicinity of said surface; a generator to supply a voltage to the electrodes to generate an electrical field having a strength in the order of 25 to 35 KV/cm at said surface of the Stratum corneum layer to inactivate bacterial cells in or on said surface. The electrodes are configured so that the strength of the electrical field reduces as a function of the depth of penetration into the skin from 25 to 35 KV/cm at said surface to 3 KV/cm or less at a depth of penetration that does not exceed 15 microns.

Abstract: A method and system for employing a medical device is disclosed. The medical device includes a housing, a processor disposed within the housing, a connector module, and a medical electrical epicardial lead connected to the processor through the connector module. The epicardial lead is used to sense a cardiac signal from tissue of a patient. The lead comprises an insulative lead body that includes a proximal end and a distal end, at least one conductor disposed in the lead body, and a side helical fixation member, disposed a distance from the distal end, the side helical fixation member. The side helical fixation member comprises a set of windings configured to wrap around the lead body circumference. The side helical fixation member includes a distal tip comprising a sharpened elongated flat free end that is perpendicular to the lead body and angled toward an inside of the set of windings.

Abstract: A collector electrode assembly which can be implanted by laparoscopy through the abdominal wall into the small pelvis of the human body includes a collector electrode for neurostimulation of nerves; a connection cable having an outer surface, said collector electrode being arranged at one end of said connection cable and comprising several outer segment electrodes which can be contacted individually and/or in groups and which are arranged axially one after another in the direction of the longitudinal extent of the collector electrode, wherein an insulating section is arranged axially between in each case two adjacent outer segment electrodes and permits electrical insulation of respective two adjacent outer segment electrodes; radially expandable fixing structures positioned on the collector electrode and radially expandable from a withdrawn position to a radially expanded position for fixing the collector electrode in place at said nerves; a visually perceptible direction marker on the outer surface of the c

Abstract: A lead anchor including a body having a first end and a second end opposite to the first end is disclosed. The body defines a lead lumen extending from the first to the second end and can receive a lead. The lead anchor also includes a fastening mechanism disposed in the body and in communication with the lead lumen. The fastening mechanism can fasten the received lead to the lead anchor when actuated by a user. The lead anchor also includes tabs(s) extending from the body and tags. Each tag includes an anchor attachment element and a cylindrical implantation element coupled to the anchor attachment element. The anchor attachment element is affixed to one of the tabs. The cylindrical implantation element anchors the lead anchor into patient tissue by insertion of the implantation element into the patient tissue using a needle insertion tool.

Abstract: An interventional medical system includes an elongate shaft, a steering assembly coupled to the shaft, a snare member, and a passageway configured to allow passage of the snare member therethrough and into a first longitudinally extending lumen of the shaft; wherein the passageway is spaced distally from the steering assembly actuator by no more than 3 cm to 3.5 cm, and the passageway includes an elastic sealing perimeter. The passageway may, in some cases, be formed in a tapered member of the steering assembly that couples a proximal end of the shaft to a core of the steering assembly.

Abstract: Provided are a closed-loop stimulating apparatus and a stimulating method thereof, where the method includes: determining a physiological status variation of a user receiving a stimulating signal according to an electrocardiogram signal of the user, and generating the stimulating signal according to a variation of the electrocardiogram signal relative to electrocardiogram history data of the user.

Abstract: Systems and related methods for controlling an ear stimulation device with a personal computing device, in response to determination of electrical contact of an electrode in a stimulator earpiece with an ear of a user of the personal computing device, are described. If the electrode is not in good electrical contact with the ear of the user, delivery of the stimulus is prevented and the user is notified of the status of the electrode. In various aspects, the user is instructed to reposition the earpiece or replace, clean, moisten, or apply gel to at least a portion of the electrode.

Abstract: A method, systems, and devices are disclosed. An example method includes determining whether an external unit of an implanted medical device is coupled to an implanted unit of the implanted medical device. In response to determining that the external unit is coupled to the implanted unit, the example method includes causing the external unit to operate in a first operating mode. In response to determining that the external unit is not coupled to the implanted unit, the example method includes causing the external unit to operate in a second operating mode.

Abstract: This document mainly discloses a method and a device for sound enhancement, both aspects of the invention hereby described are directed to cochlear implants. The method for sound enhancement and the sound enhancement device comprising a component adapted to carry out said method are based on processing the envelope for frequency bands of the acoustic signal captured, said amplification is directed to the gain value of the amplification according to an amplitude of an output signal of the other sound processor.

Abstract: A method for reducing spasticity applied with an electrical stimulation device to electrically stimulate a target zone of an organism suffering from spasticity. The electrical stimulation device comprises at least one electrical stimulation unit. The electrical stimulation unit includes at least one first electrode and at least one second electrode. The method includes the following steps. The electrical stimulation unit is placed near the target zone. The electrical stimulation unit generates an electrical stimulation signal and the electrical stimulation signal is introduced to the target zone so as to stimulate the target zone. An electric field is generated between the first electrode and the second electrode and covers the target zone. The strength of the electric field ranges from 100V/m to 1000V/m.

Abstract: An implantable pulse generator (IPG) that generates spinal cord stimulation signals for a human body has a programmable signal generator that can generate the signals based on stored signal parameters without any intervention from a processor that controls the overall operation of the IPG. While the signal generator is generating the signals the processor can be in a standby mode to substantially save battery power.

Abstract: A device may include a primary antenna configured to be located external to a subject and at least one processor in electrical communication with the primary antenna. The at least one processor may be configured to cause transmission of a primary signal from the primary antenna to an implantable device, wherein the implantable device includes at least one pair of modulation electrodes. The at least one processor may be further configured to adjust one or more characteristics of the primary signal to generate a sub-modulation control signal adapted so as not to cause a neuromuscular modulation inducing current at the at least one pair of modulation electrodes when received by the implantable device and to generate a modulation control signal adapted so as to cause a neuromuscular modulation inducing current at the at least one pair of modulation electrodes when received by the implantable device.

Abstract: Sensory information can be delivered to a subject mammal, for example, for restoring a sense of cutaneous touch and limb motion to the subject mammal. A biomimetic electrical signal is generated based on (a) a stimulation reference signal applied to a somatosensory region of a nervous system of a reference mammal, (b) a stimulated-response signal acquired from a sensory cortex of the reference mammal in response to application of the stimulation reference signal to the thalamic nucleus, and (c) a natural-response signal acquired from the sensory cortex in response to peripheral touch stimuli and/or peripheral nerve stimulation of the reference mammal. The biomimetic electrical signal is applied to a somatosensory region of a nervous system of the subject mammal to induce an activation response, in a sensory cortex of the subject mammal.

Abstract: A closed-loop brain computer interface (BCI) system for treating mental or emotional disorders with responsive brain stimulation is disclosed. The system includes an implanted module including a processor configured to process neural data acquired from one or more electrodes in communication with one or more brain regions of a patient. The implanted module is configured to deliver stimulation to electrodes in contact with the brain regions. An interface is in wireless communication with the implanted module and configured to receive the neural data from the implanted module. A controller processes the patient's brain and body signals to provide patient intentional control over the stimulation applied to the one or more electrodes and to control the stimulation.

Abstract: A method of developing a respiration pacing signal includes detecting respiration and movement activity in an implanted patient and developing corresponding respiration and movement signals. A respiration pacing signal is synchronized with the detected respiration activity and delivered to respiration neural tissue of the implanted patient to promote breathing of the implanted patient. A plurality of respiration sensing modes are used that reflect activity of the movement signal over time to optimize system power consumption over time, including: i. an active respiration mode when the movement signal is either actively changing or remains unchanged for a brief period less than some reduced activity period, wherein the respiration signal is measured continuously, and ii. a plurality of reduced activity respiration modes when the movement signal has remained unchanged for the reduced activity period, wherein the respiration signal is measured only during a limited respiration sampling period.

Abstract: Systems of techniques for controlling charge flow during the electrical stimulation of tissue. In one aspect, a method includes receiving a charge setting describing an amount of charge that is to flow during a stimulation pulse that electrically stimulates a tissue, and generating and delivering the stimulation pulse in a manner such that an amount of charge delivered to the tissue during the stimulation pulse accords with the charge setting.

Abstract: An electronic medical system is described. The system comprises an external RF power transmitter configured to emit a first power signal via an electromagnetic coupling, said RF power transmitter being configured to emit said first energy signal with a power no greater than 1W. The system further comprises an implantable medical device comprising: at least one receiver antenna configured to receive said first energy signal via an electromagnetic coupling; an RF power receiver module configured to extract a second energy signal having a power of at least 1 mW and to be powered by said second energy signal; a power actuator module, operatively connected to the RF power receiver module, powered by said second energy signal. The power actuator module is configured to deliver a medical treatment to at least a target tissue of a patient on the basis of a control signal generated by the RF power receiver module.

Abstract: An implantable micro-miniature device is disclosed. The device comprises a thin hermetic insulating coating and at least one thin metal secondary coating over the hermetic insulating layer in order to protect the insulating layer from the erosive action of body fluids or the like. In one embodiment the insulating layer is ion beam assisted deposited (IBAD) alumina and the secondary coating is titanium. The device may be a small electronic device such as a silicon integrated circuit chip. The thickness of the insulating layer may be ten microns or less and the thickness of the secondary layer may be between about 0.1 and about 15 microns.

Abstract: The disclosure describes a method and system that allows a user to configure electrical stimulation therapy by defining a three-dimensional (3D) stimulation field. After a stimulation lead is implanted in a patient, a clinician manipulates the 3D stimulation field in a 3D environment to encompass desired anatomical regions of the patient. In this manner, the clinician determines which anatomical regions to stimulate, and the system generates the necessary stimulation parameters. In some cases, a lead icon representing the implanted lead is displayed to show the clinician where the lead is relative to the 3D anatomical regions of the patient.

Abstract: An implantable medical device system includes a pacemaker and an extravascular implantable cardioverter defibrillator (ICD). The pacemaker is configured to acquire a cardiac electrical signal, determine RR intervals from the cardiac electrical signal, apply ventricular tachycardia detection criteria solely to the RR intervals, detect ventricular tachycardia (VT) when the detection criteria are met; and deliver anti-tachycardia pacing in response to detecting the VT before the extravascular ICD delivers a shock therapy.

Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.

Abstract: A wearable medical device includes a water-resistant/waterproof housing configured to be continuously or nearly continuously worn by a patient and formed from a water-resistant/waterproof material, and configured to prevent ingress of water in a wet environment; a plurality of ECG sensing electrodes configured to be removably coupled to the patient and to monitor an ECG of the patient; a plurality of therapy electrodes configured to be removably coupled to the patient and to deliver at least one therapeutic pulse to the patient; and a control unit disposed within the water-resistant/waterproof housing and configured to be electrically coupled to the plurality of ECG sensing electrodes and the plurality of therapy electrodes, the control unit configured to receive the monitored ECG of the patient, and responsive to detection of a cardiac arrhythmia, provide the at least one therapeutic pulse to the patient via the at least one therapy electrode.

Abstract: A defibrillator system and associated methodology for determining capacity of a battery and/or a number of battery cells contained in a pack. The system measures and stores the battery or battery pack voltage signal data and uses an algorithm to determine the remaining capacity. The algorithm takes into account the operating mode of the device, historical information of the device including, but not limited to, how long it has been since the device has been used, how the device has been used (e.g. shocking mode or idle mode), how many times the device has been used with its installed battery or battery pack, how many charging cycles and/or shocks have been delivered etc. The output from the system is fed back to the user to inform the user when the battery is low, needs to be replaced and/or how many remaining shocks are left the battery.

Abstract: Systems and methods for increasing skin rejuvenation of a region of a patient's skin. The system includes: a pulsed electromagnetic field (PEMF) frequency generator that emits electromagnetic pulses to the region of the patient's skin; and a deep tissue diathermy device that applies heat to the region of the patient's skin up to temperature T. The system simultaneously applies the heat and the PEMF to the region of a patient's skin.

Abstract: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength ?1, to generate a second wavelength ?2 of radiation having a higher energy than the first wavelength ?1.